Treating Cardiopulmonary Disease with Inhaled Targeted Therapies

Josh Ziel, chief operating officer and interim CEO of Aerami, discusses pulmonary arterial hypertension, the company’s experimental therapy to treat the condition, and the company’s precision inhalation technology, and its efforts to build a pipeline of therapies that make use of its proprietary inhalation technology.